ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 8 filers reported holding ESSA PHARMA INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $461 | +6.2% | 149,143 | -7.2% | 0.00% | +100.0% |
Q2 2023 | $434 | -30.0% | 160,643 | -23.1% | 0.00% | -50.0% |
Q1 2023 | $620 | +48.7% | 208,791 | +26.1% | 0.00% | +100.0% |
Q4 2022 | $417 | -99.7% | 165,641 | +114.5% | 0.00% | 0.0% |
Q3 2022 | $141,000 | -52.7% | 77,236 | -18.3% | 0.00% | 0.0% |
Q2 2022 | $298,000 | -58.1% | 94,578 | -17.9% | 0.00% | -50.0% |
Q1 2022 | $712,000 | -40.5% | 115,232 | +36.8% | 0.00% | -33.3% |
Q4 2021 | $1,196,000 | +896.7% | 84,230 | +738.1% | 0.00% | – |
Q4 2020 | $120,000 | +73.9% | 10,050 | 0.0% | 0.00% | – |
Q3 2020 | $69,000 | +11.3% | 10,050 | 0.0% | 0.00% | – |
Q2 2020 | $62,000 | +55.0% | 10,050 | 0.0% | 0.00% | – |
Q1 2020 | $40,000 | -27.3% | 10,050 | 0.0% | 0.00% | – |
Q4 2019 | $55,000 | +61.8% | 10,050 | 0.0% | 0.00% | – |
Q3 2019 | $34,000 | +36.0% | 10,050 | 0.0% | 0.00% | – |
Q2 2019 | $25,000 | -26.5% | 10,050 | 0.0% | 0.00% | – |
Q1 2019 | $34,000 | +61.9% | 10,050 | 0.0% | 0.00% | – |
Q4 2018 | $21,000 | -30.0% | 10,050 | 0.0% | 0.00% | – |
Q3 2018 | $30,000 | -21.1% | 10,050 | 0.0% | 0.00% | – |
Q2 2018 | $38,000 | – | 10,050 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Soleus Capital Management, L.P. | 4,287,094 | $13,247,120 | 1.22% |
BVF INC/IL | 8,748,629 | $27,033,264 | 0.73% |
PFM Health Sciences, LP | 4,199,253 | $12,975,692 | 0.61% |
Bellevue Group AG | 7,898,583 | $24,406,621 | 0.39% |
Rhenman & Partners Asset Management AB | 356,500 | $1,101,585 | 0.12% |
Rock Springs Capital Management LP | 677,005 | $2,091,945 | 0.06% |
Orbimed Advisors | 842,366 | $2,602,911 | 0.06% |
Privium Fund Management (UK) Ltd | 20,032 | $61,098 | 0.05% |
Hunting Hill Global Capital, LLC | 10,000 | $30,900 | 0.01% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,042,531 | $3,221,421 | 0.01% |